Catalyst Wire Dossier Catalyst Wire Dossier

Mixed Bacteria Vaccine (MBV)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Mixed Bacteria Vaccine (MBV), covering 2017-01-09 to 2017-01-09. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen [Phase 1]

See pricing